Rating History for Kymera Therapeutics (KYMR) by Barclays
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 1/28/2026 | Eliana Merle | New Coverage | Overweight (N/A) |
313.00 (N/A) |
71.06 (83.49) |
17.49% | Details |
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 1/28/2026 | Eliana Merle | New Coverage | Overweight (N/A) |
313.00 (N/A) |
71.06 (83.49) |
17.49% | Details |
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||